Epilepsy Research
Volume 24, Issue 1 , Pages 19-28 , May 1996

Lamotrigine vs. phenytoin for treatment of status epilepticus: comparison in an experimental model

Received 22 September 1995 ,Accepted 8 January 1996.

References 

  1. Altrup U, Gerlach G, Reith H, Said MN, Speckmann E-J. Effects of valproate in a model nervous system (buccal ganglia of Helix pomatia): I. Antiepileptic actions. Epilepsia. 1992;33:743–752
  2. Epilepsy Foundation of America . Treatment of convulsive status epilepticus. J. Am. Med. Assoc. 1993;270:854–859
  3. Fazio A, Artesi C, Russo M, Trio R, Oteri G, Pisani F. A liquid chromatographic assay using a high-speed column for the determination of lamotrigine, a new antiepileptic drug, in human plasma. Ther. Drug Monit. 1992;14:509–512
  4. Kapur J, Lothman EW. NMDA receptor activation mediates the loss of GABAergic inhibition induced by recurrent seizures. Epilepsy Res. 1991;5:103–111
  5. Kapur J, Stringer JL, Lothman EW. Evidence that repetitive seizures in the hippocampus cause a lasting reduction of GABAergic inhibition. J. Neurophysiol. 1989;61:417–426
  6. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia. 1986;27:490–497
  7. Litchfield JT, Wilcoxon F. A simplified method of evaluating dose-effect experiments. J. Pharmacol. Exp. Ther. 1949;96:99–113
  8. Loescher W, Hoenack D, Taylor CP. Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain. Neurosci. Lett. 1991;128:150–154
  9. Macdonald RL, Kelly KM. Antiepileptic drug mechanisms of action. Epilepsia. 1995;36(Suppl. 2):S2–S12
  10. McLean MJ. Gabapentin. Epilepsia. 1995;36(Suppl. 2):S73–S86
  11. Messenheimer JH. Lamotrigine. Epilepsia. 1995;36(Suppl. 2):S87–S94
  12. Michelson HB, Kapur J, Lothman EW. Reduction of paired pulse inhibition in the CA1 region of the hippocampus in status epilepticus induced by pilocarpine in naive and in amygdala-kindled rats. Exp. Neurol. 1989;104:264–271
  13. Miller AA, Wheatley PL, Sawyer DA, Baxter MG, Roth B. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: I: anticonvulsant profile in mice and rats. Epilepsia. 1986;27:483–489
  14. Rowan AJ, Binnie CD, Warfield CA, Meinardi H, Meijer JWA. The delayed effect of sodium valproate on the photoconvulsive response in man. Epilepsia. 1979;20:61–68
  15. Taylor CP. Emerging perspectives on the mechanism of action of gabapentin. Neurology. 1994;44(Suppl. 5):S10–S16
  16. Treiman DM, Meyers PD, Walton NY  DVA Status Epilepticus Cooperative Study Group. Duration of generalized convulsive status epilepticus (GCSE): relationship to clinical symptomatology and response to treatment. Epilepsia. 1992;33(Suppl. 3):67
  17. Walton NY, Gunawan S, Treiman DM. Treatment of experimental status epilepticus with the GABA uptake inhibitor, tiagabine. Epilepsy Res. 1994;19:237–244
  18. Walton NY, Treiman DM. Experimental secondarily generalized convulsive status epilepticus induced by D,L-homocysteine thiolactone. Epilepsy Res. 1988;2:79–86
  19. Walton NY, Treiman DM. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp. Neurol. 1988;101:267–275
  20. Walton NY, Treiman DM. Phenobarbital treatment of status epilepticus in a rodent model. Epilepsy Res. 1989;4:216–221
  21. Walton NY, Treiman DM. Efficacy of ACC-9653 (a phenytoin prodrug) in experimental status epilepticus in the rat. Epilepsy Res. 1990;5:165–168
  22. Walton NY, Treiman DM. Lorazepam treatment of experimental status epilepticus in the rat: relevance to clinical practice. Neurology. 1990;40:990–994
  23. Walton NY, Treiman DM. Vaproic acid treatment of experimental status epilepticus. Epilepsy Res. 1992;12:199–205
  24. Walton NY, Treiman DM. Efficacy of a new NMDA receptor antagonist in treatment of experimental status epilepticus. Epilepsia. 1993;34(Suppl. 6):52
  25. Winer BJ. Statistical Principles in Experimental Design. In: New York, NY: McGraw-Hill; 1962;p. 907

PII: 0920-1211(96)00007-1

Epilepsy Research
Volume 24, Issue 1 , Pages 19-28 , May 1996